Anti HER 2/ neu antibody is:
**Core Concept**
The question tests knowledge of targeted cancer therapies, specifically **monoclonal antibodies** used in the treatment of certain cancers. **HER2/neu** is a receptor tyrosine kinase that, when overexpressed in breast cancer, is associated with a more aggressive disease course.
**Why the Correct Answer is Right**
Trastuzumab is a **monoclonal antibody** that targets the **HER2/neu receptor**, preventing receptor dimerization and thereby inhibiting tumor growth. It is used in the treatment of **HER2-positive breast cancer**.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect as it is not specified.
**Option B:** Incorrect as it is not specified.
**Option C:** Incorrect as it is not specified.
**Option D:** Incorrect as it is not specified, but Trastuzumab is the correct answer.
**Clinical Pearl / High-Yield Fact**
Trastuzumab has significantly improved outcomes in **HER2-positive breast cancer**, making it a crucial component of treatment regimens for this subtype of breast cancer.
**Correct Answer:** D. Trastuzumab